1. Home
  2. OMH vs HOWL Comparison

OMH vs HOWL Comparison

Compare OMH & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$1.25

Market Cap

28.7M

Sector

Finance

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.78

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
HOWL
Founded
2015
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
30.7M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
OMH
HOWL
Price
$1.25
$0.78
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
23.9K
325.6K
Earning Date
11-28-2025
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.53
52 Week High
$4.33
$2.23

Technical Indicators

Market Signals
Indicator
OMH
HOWL
Relative Strength Index (RSI) 48.78 52.58
Support Level $1.03 $0.56
Resistance Level $1.37 $0.90
Average True Range (ATR) 0.09 0.08
MACD 0.00 -0.00
Stochastic Oscillator 60.98 42.16

Price Performance

Historical Comparison
OMH
HOWL

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: